Purpose. Studies focusing on safety outcomes typically require large populations to
comprehensively characterise the patient groups exposed to the medicines under …

Introduction Despite many research efforts, current data on the safety of medicines during
breastfeeding are either fragmented or lacking, resulting in restrictive labeling of most …

Introduction Information on the impact of medicines on breastfeeding and the breastfed
infant remains scarce. The aims of this review were to identify databases and cohorts …

Editorial describes spontaneous reports of adverse drug reactions (ADRs) of drugs
transmitted via breast milk based on data included in the French pharmacovigilance …

Background Clinical advice may suggest discontinuing breastfeeding after the diagnosis of
phenylketonuria in infants as the only effective way to monitor the newborn's intake and …

Although medication use during pregnancy is common, most available products lack
sufficient safety information. As prospective data collection and perinatal …

Background Breastfeeding information stored within electronic health records (EHR) has
recently been used for pharmacoepidemiological research, however the data are primarily …

Purpose Using a novel, electronic health record (EHR)‐based approach, to estimate the
prevalence of prescription medication use at 2, 4, and 6 months postpartum among lactating …

Objective: to explore the multiple aspects of this connection, addressing both the cognitive
benefits of exclusive breastfeeding and the underlying mechanisms that underlie this …

Background Managing mental disorders in the perinatal period is a challenge. The most
common mental disorders encountered in this period are major depression, bipolar disorder …